S. 3794In Committee
SAFE Drugs Act of 2026
Increase federal oversight of drug compounding and set statutory limits and reporting rules for compounded drugs that copy commercially available drugs
Plain-English overview
What this bill does
Increase federal oversight of drug compounding and set statutory limits and reporting rules for compounded drugs that copy commercially available drugs
Key points
- Require annual compounding reports
- Require outsourcing facility inspections
- Increase copy compounding limit
Current status
Where it stands
Status
In Committee
Latest action
2026-02-05 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedHealth